Jonathan Violin's Net Worth
$15.8 Million
Who is Jonathan Violin?
Jonathan Violin has an estimated net worth of $15.8 Million. This is based on reported shares across multiple companies, which include MIRAGEN THERAPEUTICS, INC., TREVENA INC, Astria Therapeutics, Inc., and Dianthus Therapeutics, Inc. /DE/.
SEC CIK
Jonathan Violin's CIK is 0001730615
Past Insider Trading and Trends
2021 was Jonathan Violin's most active year for acquiring shares with 5 total transactions. Jonathan Violin's most active month to acquire stocks was the month of May. 2022 was Jonathan Violin's most active year for disposing of shares, totalling 9 transactions. Jonathan Violin's most active month to dispose stocks was the month of January. 2023 saw Jonathan Violin paying a total of $7,500.00 for 70,600 shares, this is the most they've acquired in one year. In 2023 Jonathan Violin cashed out on 150,000 shares for a total of $3,680,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Viridian Therapeutics, Inc.\DE (VRDN) Snapshot price: $14.09
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
—
|
0
|
$18.47 | -$1,832,500.00 | 480.9K |
Scheduled
|
Feb 2
| ||
Form 4
| -10.40% | -50.00K |
$36.80 | -$1,840,000.00 | 430.9K |
Scheduled
|
Feb 2
| ||
Form 4
| -5.87% | -30.00K |
$12.20 | -$366,000.00 | 480.9K |
Scheduled
|
Jun 1
| ||
Form 4
| -5.55% | -30.00K |
$13.04 | -$391,200.00 | 510.9K |
Scheduled
|
May 2
| ||
Form 4
| -5.25% | -30.00K |
$18.92 | -$567,636.00 | 540.9K |
Scheduled
|
Apr 1 - Apr 4
| ||
Form 4
| -4.99% | -30.00K |
$17.65 | -$529,491.24 | 570.9K |
Scheduled
|
Mar 1 - Mar 2
| ||
Form 4
| -4.76% | -30.00K |
$19.09 | -$572,818.29 | 600.9K |
Scheduled
|
Feb 1 - Feb 3
| ||
Form 4
| +18,783.72% | 627.56K |
—
|
—
| 630.9K |
Dec 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 18
| |||
Form 4
|
∞
| 50.12K |
—
|
—
| 50.12K |
Oct 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TREVENA INC (TRVN) Snapshot price: $3.83
SVP-Scientific Affairs & IR
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Astria Therapeutics, Inc. (ATXS) Snapshot price: $11.12
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
| 263.32K |
Sep 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Dianthus Therapeutics, Inc. /DE/ (DNTH) Snapshot price: $26.62
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||